AXOGEN INC (AXGN) — insider trading
Health Care · NASDAQ
AXOGEN INC (AXGN) has 46 reported SEC Form 4 insider transactions in our data, including 11 open-market sales among the most recent 46 (latest 2026-09-02).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | TYNDALL JOSEPH A. | Director | Open-market sale | 3,500 | $49.70 | $173.9K | Form 4 |
| 2026-08-11 | Wendell Amy McBride | Director | Option exercise / conversion (derivative) | 13,353 | — | $0 | Form 4 |
| 2026-08-11 | Wendell Amy McBride | Director | Open-market sale | 13,353 | $48.42 | $646.6K | Form 4 |
| 2026-08-11 | Wendell Amy McBride | Director | Option exercise / conversion | 13,353 | $14.85 | $198.3K | Form 4 |
| 2026-08-10 | Began Marc A | Officer (EVP & General Counsel) | Option exercise / conversion (derivative) | 67,500 | — | $0 | Form 4 |
| 2026-08-10 | Began Marc A | Officer (EVP & General Counsel) | Open-market sale | 67,500 | $47.35 | $3.20M | Form 4 |
| 2026-08-10 | Began Marc A | Officer (EVP & General Counsel) | Option exercise / conversion | 67,500 | $8.16 | $550.8K | Form 4 |
| 2026-08-07 | Weiler Kathy Johnson | Director | Open-market sale | 14,150 | $45.30 | $641.0K | Form 4 |
| 2026-06-24 | Wendell Amy McBride | Director | Grant / award / vesting (derivative) | 4,392 | — | $0 | Form 4 |
| 2026-06-24 | Weiler Kathy Johnson | Director | Grant / award / vesting (derivative) | 4,392 | — | $0 | Form 4 |
| 2026-06-24 | TYNDALL JOSEPH A. | Director | Grant / award / vesting (derivative) | 4,392 | — | $0 | Form 4 |
| 2026-06-24 | THOMAS PAUL | Director | Grant / award / vesting (derivative) | 5,579 | — | $0 | Form 4 |
| 2026-06-24 | Levine Alan M | Director | Grant / award / vesting (derivative) | 4,392 | — | $0 | Form 4 |
| 2026-06-24 | JOHNSON JOHN | Director | Grant / award / vesting (derivative) | 4,392 | — | $0 | Form 4 |
| 2026-06-24 | Burke William P. Mr. | Director | Grant / award / vesting (derivative) | 4,392 | — | $0 | Form 4 |
| 2026-06-19 | Burke William P. Mr. | Director | Option exercise / conversion (derivative) | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | Burke William P. Mr. | Director | Option exercise / conversion | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | JOHNSON JOHN | Director | Option exercise / conversion (derivative) | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | JOHNSON JOHN | Director | Option exercise / conversion | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | TYNDALL JOSEPH A. | Director | Option exercise / conversion (derivative) | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | TYNDALL JOSEPH A. | Director | Option exercise / conversion | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | THOMAS PAUL | Director | Option exercise / conversion (derivative) | 18,867 | — | $0 | Form 4 |
| 2026-06-19 | THOMAS PAUL | Director | Option exercise / conversion | 18,867 | — | $0 | Form 4 |
| 2026-06-19 | Wendell Amy McBride | Director | Option exercise / conversion (derivative) | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | Wendell Amy McBride | Director | Option exercise / conversion | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | Weiler Kathy Johnson | Director | Option exercise / conversion (derivative) | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | Weiler Kathy Johnson | Director | Option exercise / conversion | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | Levine Alan M | Director | Option exercise / conversion (derivative) | 14,150 | — | $0 | Form 4 |
| 2026-06-19 | Levine Alan M | Director | Option exercise / conversion | 14,150 | — | $0 | Form 4 |
| 2026-05-08 | Wendell Amy McBride | Director | Option exercise / conversion (derivative) | 1,647 | — | $0 | Form 4 |
| 2026-05-08 | Wendell Amy McBride | Director | Open-market sale | 1,647 | $42.60 | $70.2K | Form 4 |
| 2026-05-08 | Wendell Amy McBride | Director | Option exercise / conversion | 1,647 | $14.85 | $24.5K | Form 4 |
| 2026-05-07 | Quackenbush Doris | Officer (Sales VP) | Open-market sale | 3,878 | $43.51 | $168.7K | Form 4 |
| 2026-05-07 | Hartley Lindsey Marie | Officer (CFO) | Option exercise / conversion (derivative) | 2,963 | — | $0 | Form 4 |
| 2026-05-07 | Hartley Lindsey Marie | Officer (CFO) | Option exercise / conversion (derivative) | 2,500 | — | $0 | Form 4 |
| 2026-05-07 | Hartley Lindsey Marie | Officer (CFO) | Open-market sale | 573 | $43.67 | $25.0K | Form 4 |
| 2026-05-07 | Hartley Lindsey Marie | Officer (CFO) | Option exercise / conversion | 2,963 | $8.27 | $24.5K | Form 4 |
| 2026-05-07 | Hartley Lindsey Marie | Officer (CFO) | Open-market sale | 478 | $43.67 | $20.9K | Form 4 |
| 2026-05-07 | Hartley Lindsey Marie | Officer (CFO) | Option exercise / conversion | 2,500 | $8.20 | $20.5K | Form 4 |
| 2026-05-07 | Kemp Jens | Officer (Chief Marketing Officer) | Open-market sale | 4,000 | $43.44 | $173.8K | Form 4 |
| 2026-05-07 | Weiler Kathy Johnson | Director | Option exercise / conversion (derivative) | 16,344 | — | $0 | Form 4 |
| 2026-05-07 | Weiler Kathy Johnson | Director | Open-market sale | 16,344 | $44.09 | $720.6K | Form 4 |
| 2026-05-07 | Weiler Kathy Johnson | Director | Option exercise / conversion | 16,344 | $6.95 | $113.6K | Form 4 |
| 2026-05-07 | JOHNSON JOHN | Director | Option exercise / conversion (derivative) | 11,050 | — | $0 | Form 4 |
| 2026-05-07 | JOHNSON JOHN | Director | Open-market sale | 11,050 | $43.26 | $478.0K | Form 4 |
| 2026-05-07 | JOHNSON JOHN | Director | Option exercise / conversion | 11,050 | $7.04 | $77.8K | Form 4 |
Ask the chat about AXGN's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: AXOGEN INC (AXGN).
Last updated 2026-09-02 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.